Metronomic doses and drug schematic combination response tested within chambered coverslips for the treatment of breast cancer cells (JIMT-1).

Low-dose metronomic (LDM) chemotherapy is an alternative to conventional chemotherapy and is the most frequently used approach in low dose chemotherapy regimens. The selection of patients, drug dosages, and dosing intervals in LDM is empirical. In this study, we systematically examined the schedule-...

Full description

Bibliographic Details
Main Authors: Gustavo Rosero, Gisela Pattarone, Ana Peñaherera, Julia Pilz, Joschka Bödecker, Maximiliano Perez, Roland Mertelsmann, Betiana Lerner, Marie Follo
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0274911